| 产品详情 |
| Edit |   |
|---|
| Product Name | Ro 6842262 |
|---|
| Description | Potent LPA1 antagonist (IC50 = 25 nM). Exhibits >1,200-fold selectivity for LPA1 over LPA3. Attenuates NHLF human lung fibroblast cell proliferation and contraction in vitro. Also reduces plasma histamine levels in mouse LPA-challenge model. Orally bioavailable. Purity 98%. MW (observed): 482.53 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1-[4'-[4-Methyl-5-[[[(1R)-1-phenylethoxy]carbonylamino]-1H-1,2,3-triazol-1-yl][1,1'-biphenyl]-4-yl]cyclopropanecarboxylic acid |
|---|
| Gene, Accession, CAS # | CAS: 1396006-71-5 |
|---|
| Catalog # | 5913/10 |
|---|
| Price | |
|---|
| Order / More Info | Ro 6842262 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|